Analysis Data Model (AdAM)

SDTM,analysis,metadata,source,domains,traceability,review,subject-level analysis dataset,trial,format,tools,contents,description,fundamental principle,record per subject,unambiguous communication,statistical programmers,analyses,clinical trials,clinical trial design,discussions,industries,column,form,ADaM datasets,regulatory submissions.

Adverse events,analysis parameters,analysis populations,analysis variables,secondary efficacy analysis values,statistical analysis,type of analysis,readable metadata,standard domains,domain classes,statistical analyses,terms of traceability,raw sources,non-clinical data.

Common software tools,industry leaders,benefits,demographics records,record,communication,adverse events column,core,core model,development,regulatory authorities,baseline characteristics,CDISC-based submission,collection instrument,database lock,device developers,essential component,output creation,product approval,prognostic factors,records per subject,Regulatory agency staff,simple merging,standardized programs,subject disposition,supplemental qualifier,wider family.

ADaM standards,Additional variables,CRF variables,clinical studies,Implementation Guide,electronic submissions,definition files,single file,regulatory agencies,interoperability between software,datasets for display,analysis datasets,CDISC Analysis Data Model Team,”CDISC Analysis Data Model Team,”,Center for Applied Data Analysis,application of analysis data,ADaM subject-level analysis dataset,analysis approach,analysis data model,Analysis data sets,analysis data standards,analysis data standards initiatives,analysis ready,analysis time,analysis timepoint,analysis values,creation of analysis datasets,datasetsThe Analysis Data Model Implementation Guide,function for analysis datasets,analysis-ready statistical analysis,clinical data analysis,collection to analysis,cross-study analysis,database for analysis,future analysis,clinical trial automation software,clinical trial process,Clinical Trial Registries,clinical trial submission,entire trial,automation of metadata,essentially metadata,interchange of metadata,machine-readable metadata,standardized domains,actual domains,classes of domains,SDTM datasets,SDTM implementation,ADaM. Assessing SDTM,CDISC SDTM v3.1.2,standard format,common data format,independent format,machine-readable (XML) format,categorical analyses,continuous analyses,continuous value analyses,Event Analyses,in-built traceability,level of traceability,authoritative source,flow from source values,Post-Pandemic Teaching Discussion Group,discussion of computing needs,faculty in discussion,clinical and non-clinical data submissions,clinical and non-clinical research,clinical and non-clinical use,CDISC-aware tool,interdisciplinary tools,industry level,industry professional,drug review efficiency,efficient review,content of datasets submitted,content standards,Key Benefits,maximum benefit,detailed description,machine-readable, interchangeable descriptions,basic principles,key principles,communication between users,blank columns,core expertise,development expenses,development plan,report forms,enquiry form.